Primary hyperaldosteronism

Changed by Henry Knipe, 16 Sep 2014

Updates to Article Attributes

Body was changed:

Conn syndrome (or primary hyperalderosteronism) is a condition of excess of aldosterone production. This entity is due and occurs secondary to an autonomous solitary adrenal adrenal cortical adenoma in 80% of cases, bilateral adrenal hyperplasia, or rarely, adrenal carcinoma. Excess secretion of aldosterone can also occur in renin-related hypertensionDifferentiation between the causes is required to avoid unnecessary surgery

Clinical and laboratary featurespresentation

ItConn syndrome typically presents typically with diastolic hypertension, metabolic alkalosis, and hypokalaemia.

Primary hyperaldosteronism is distinguished from secondary hyperaldosteronism by measurement of serum renin; renin levels are low in the former and high in the latter.

Clinically, Conn's syndrome is characterized by hypertension, muscular Other symptoms include muscular weakness, paresthesias, headache, polyuria, and polydipsia. Oedema is rare in these patients.

Pathology

Primary hyperaldosteronism is distinguished from secondary hyperaldosteronism by measurement of serum renin:

  • primary: low renin levels
  • secondary: high renin levels
Aetiology

Conn syndrome is due to an autonomous solitary adrenal cortical adenoma in 80% of cases, with the remainder almost entirely due to bilateral adrenal hyperplasia with adrenal carcinoma being a rare cause. 

Excess secretion of aldosterone can also occur in renin-related hypertension. 

Markers

Biochemical analysis may demonstrate hypokalaemia, which may be the first clue to the diagnosis of aldosteronoma in a patient being evaluated for hypertension. The baseline plasma aldosterone is usually greater than 20 g/dL.

Radiological diagnosisRadiographic features

Most aldosteronomas are less than 2 cm in diameter and unilateral in 95% of cases. Assay of aldosterone levels in blood obtained via selective catheterization of both adrenal veins is the most reliable diagnostic procedure. Selective adrenal arteriography, adrenal phlebography, radionuclide studies and CT scans are helpful in diagnosis. Adrenal adenomas in this conditionConn syndrome tend to be quiteunilateral (95%) quite small, often 0.6-1.5~ 2 cm (range 1-5 cm) in diameter, and can be a challenge to detect, even by CT or MR imaging.

Selective adrenal arteriography, venous sampling, adrenal phlebography, radionuclide studies and CT scans are helpful in diagnosis. 

CT

On CT,

  • aldosteronomas are homogeneous and often hypodense, with an attenuation value near that of water. CT (<10 HU)
  • none or minimal contrast enhancement
  • rarely calcify
  • detects 70% of aldosteronomas, although small lesions may be missed. If
  • if CT findings are negative, selective adrenal venous sampling for aldosterone or a dexamethasone suppressed iodocholesterol adrenal scan may identify the lesion
Angiography

Adrenal venous sampling to assay aldosterone serum via selective catheterization of both adrenal veins, may still only be helpful in ~50% of cases.

Treatment and prognosis

If a solitary adrenal mass is detected, surgical adrenalectomy will correct hypertension in 75% 90-90% of cases. Adrenal hyperplasia is the cause in most of the remaining 20% of cases of Conn's syndrome, with adrenal carcinoma occurring rarely. Bilateral adrenalectomy in patients with hyperplasia is not usually an effective treatment and results in adrenal insufficiency and is usually treated medically. Thus differentiation between the causes is required to avoid unnecessary surgery. 

EtymologyHistory and etymology

It is named after J W Conn, who first described the condition in 1955 4.

See also

  • -<p><strong>Conn syndrome</strong> (or <strong>primary hyperalderosteronism </strong>) is a condition of excess of aldosterone production. This entity is due to an autonomous solitary <a href="/articles/adrenal_adenoma">adrenal cortical adenoma</a> in 80% of cases. Excess secretion of aldosterone can also occur in renin-related hypertension. </p><h4>Clinical and laboratary features</h4><p>It presents typically with diastolic hypertension, metabolic alkalosis, and hypokalaemia.</p><p>Primary hyperaldosteronism is distinguished from secondary hyperaldosteronism by measurement of serum renin; renin levels are low in the former and high in the latter.</p><p>Clinically, Conn's syndrome is characterized by hypertension, muscular weakness, paresthesias, headache, polyuria, and polydipsia. Oedema is rare in these patients. Biochemical analysis may demonstrate hypokalaemia, which may be the first clue to the diagnosis of aldosteronoma in a patient being evaluated for hypertension. The baseline plasma aldosterone is usually greater than 20 g/dL.</p><h4>Radiological diagnosis</h4><p>Most aldosteronomas are less than 2 cm in diameter and unilateral in 95% of cases. Assay of aldosterone levels in blood obtained via selective catheterization of both adrenal veins is the most reliable diagnostic procedure. Selective adrenal arteriography, adrenal phlebography, radionuclide studies and CT scans are helpful in diagnosis. Adrenal adenomas in this condition tend to be quite small, often 0.6-1.5 cm in diameter, and can be a challenge to detect, even by CT or MR imaging.</p><h5>CT</h5><p>On CT, aldosteronomas are homogeneous and often hypodense, with an attenuation value near that of water. CT detects 70% of aldosteronomas, although small lesions may be missed. If CT findings are negative, selective adrenal venous sampling for aldosterone or a dexamethasone suppressed iodocholesterol adrenal scan may identify the lesion.</p><h4>Treatment and prognosis</h4><p>If a solitary adrenal mass is detected, surgical adrenalectomy will correct hypertension in 75% 90% of cases. <a href="/articles/adrenal-hyperplasia">Adrenal hyperplasia</a> is the cause in most of the remaining 20% of cases of Conn's syndrome, with adrenal carcinoma occurring rarely. Bilateral adrenalectomy in patients with hyperplasia is not usually an effective treatment and results in adrenal insufficiency.</p><h4>Etymology</h4><p>It is named after <strong>J W Conn</strong>, who first described the condition in 1955 <sup>4</sup>.</p><h4>See also</h4><ul><li><a href="/articles/adrenal_adenoma">adrenal adenoma</a></li></ul>
  • +<p><strong>Conn syndrome</strong> (or <strong>primary hyperalderosteronism</strong>) is a condition of excess of aldosterone production and occurs secondary to adrenal cortical adenoma, bilateral adrenal hyperplasia, or rarely, adrenal carcinoma. Differentiation between the causes is required to avoid unnecessary surgery. </p><h4>Clinical presentation</h4><p>Conn syndrome typically presents with diastolic hypertension, metabolic alkalosis, and hypokalaemia. Other symptoms include muscular weakness, paresthesias, headache, polyuria, and polydipsia. Oedema is rare in these patients. </p><h4>Pathology</h4><p>Primary hyperaldosteronism is distinguished from secondary hyperaldosteronism by measurement of serum renin:</p><ul>
  • +<li>primary: low renin levels</li>
  • +<li>secondary: high renin levels</li>
  • +</ul><h5>Aetiology</h5><p>Conn syndrome is due to an autonomous solitary <a href="/articles/adrenal-adenoma">adrenal cortical adenoma</a> in 80% of cases, with the remainder almost entirely due to bilateral <a title="Adrenal hyperplasia" href="/articles/adrenal-hyperplasia">adrenal hyperplasia</a> with <a title="Adrenal carcinoma" href="/articles/adrenal-cortical-carcinoma-1">adrenal carcinoma</a> being a rare cause. </p><p>Excess secretion of aldosterone can also occur in renin-related hypertension. </p><h5>Markers</h5><p>Biochemical analysis may demonstrate hypokalaemia, which may be the first clue to the diagnosis of aldosteronoma in a patient being evaluated for hypertension. The baseline plasma aldosterone is usually greater than 20 g/dL.</p><h4>Radiographic features</h4><p>Adrenal adenomas in Conn syndrome tend to be unilateral (95%) quite small, often ~ 2 cm (range 1-5 cm) in diameter, and can be a challenge to detect, even by CT or MR imaging.</p><p>Selective adrenal arteriography, venous sampling, adrenal phlebography, radionuclide studies and CT scans are helpful in diagnosis. </p><h5>CT</h5><ul>
  • +<li>aldosteronomas are homogeneous and often hypodense, with an attenuation value near that of water (&lt;10 HU)</li>
  • +<li>none or minimal contrast enhancement</li>
  • +<li>rarely calcify</li>
  • +<li>detects 70% of aldosteronomas, although small lesions may be missed</li>
  • +<li>if CT findings are negative, selective adrenal venous sampling for aldosterone or a dexamethasone suppressed iodocholesterol adrenal scan may identify the lesion</li>
  • +</ul><h5>Angiography</h5><p>Adrenal venous sampling to assay aldosterone serum via selective catheterization of both adrenal veins, may still only be helpful in ~50% of cases. </p><h4>Treatment and prognosis</h4><p>If a solitary adrenal mass is detected, surgical adrenalectomy will correct hypertension in 75-90% of cases. Bilateral adrenalectomy in patients with hyperplasia is not usually an effective treatment and results in <a title="adrenal insufficiency" href="/articles/adrenal-insufficiency">adrenal insufficiency</a> and is usually treated medically. Thus differentiation between the causes is required to avoid unnecessary surgery. </p><h4>History and etymology</h4><p>It is named after <strong>J W Conn</strong>, who first described the condition in 1955 <sup>4</sup>.</p><h4>See also</h4><ul><li><a href="/articles/adrenal-adenoma">adrenal adenoma</a></li></ul>

References changed:

  • 5. Andy Adam. Grainger & Allison's Diagnostic Radiology. (2015) ISBN: 9780702042959 - <a href="http://books.google.com/books?vid=ISBN9780702042959">Google Books</a>

Sections changed:

  • Syndromes
Images Changes:

Image 3 CT (non-contrast) ( create )

Image 4 DSA (angiography) (Frontal) ( create )

ADVERTISEMENT: Supporters see fewer/no ads